Eli Lilly, Nvidia team up on AI-powered drug discovery pact; FDA chief's bid to speed drug reviews hits turbulence; Largest ...

MM+M’s Steve Madden is at the JPM Healthcare Conference this week, and he’ll be providing running commentary from the event.

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...

The company’s previous CCO was Cristal Downing, who joined Insulet as chief corporate affairs officer late last year.

Leveraging AI in a way that preserves the planet should be a top priority for healthcare marketers and medical communications ...

The FDA’s Office of Prescription Drug Promotion asserted that BeOne’s Teams backgrounds made benefit claims without providing ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...

Incyte’s The Power of Choice campaign was supported by two 2025 MM+M Agency 100 honorees: Klick and Real Chemistry.

For vaccine schedules, the U.S. is now the outlier; Merck in talks to ​buy ‌Revolution Medicines for up to $32 billion; Lilly ...

If the weather forecast is to be believed, something miraculous is about to happen in San Francisco. For the first time in ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

Real Chemistry unveiled its new advisory practice, focused on corporate communications and reputation, in advance of the ...